Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Did you mean
fumi okada
(12 results)?
A longitudinal study of anti-SARS-CoV-2 antibody seroprevalence in a random sample of the general population in Hiroshima in 2020.
Environ Health Prev Med. 2022;27:30. doi: 10.1265/ehpm.22-00016.
Environ Health Prev Med. 2022.
PMID: 35793938
Free PMC article.
Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima.
Ko K, Takahashi K, Nagashima S, E B, Ouoba S, Takafuta T, Fujii Y, Mimori M, Okada F, Kishita E, Ariyoshi K, Hussain MRA, Sugiyama A, Akita T, Kuwabara M, Tanaka J.
Ko K, et al. Among authors: okada f.
Viruses. 2022 Mar 30;14(4):720. doi: 10.3390/v14040720.
Viruses. 2022.
PMID: 35458450
Free PMC article.
Item in Clipboard
Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan.
Ko K, Takahashi K, Nagashima S, E B, Ouoba S, Hussain MRA, Akita T, Sugiyama A, Sakaguchi T, Tahara H, Ohge H, Ohdan H, Kubo T, Ishikawa N, Takafuta T, Fujii Y, Mimori M, Okada F, Kishita E, Ariyoshi K, Kuwabara M, Tanaka J.
Ko K, et al. Among authors: okada f.
Sci Rep. 2022 Feb 14;12(1):2419. doi: 10.1038/s41598-022-04952-2.
Sci Rep. 2022.
PMID: 35165301
Free PMC article.
Item in Clipboard
Cite
Cite